We report the biochemical and molecular characterization of two new transthyretin (TTR) variants in two Italian families with hereditary amyloidosis. Both families presented neuropathy and cardiomyopathy but they differ in other clinical features. These TTR variants were previously detected by isoelectric focusing (IEF); one is a neutral TTR variant and the other one is basic. By protein and DNA analysis the neutral variant was found to have a substitution of an alanine for a threonine residue at position 49 (TTR Ala-49) of the polypeptide chain. The basic variant has a glutamine residue replacing glutamate at position 89 (TTR Gln-89)
Transthyretin-related hereditary (TTR) amyloidoses represent a clinically heterogeneous group of dis...
Familial amyloidotic polyneuropathy is a rare autosomal dominant disease, with clinical symptoms beg...
Abstract Transthyretin (TTR)-related familial amyloid polyneuropathy (TTR-FAP) is a life-threatening...
As part of an epidemiological study that aims to characterize chemically the mutation(s) in transthy...
We report on the genetic and molecular characterisation of an Italian family with a late-onset, auto...
Two unrelated Italian families affected by hereditary amyloidosis are described. Molecular genetic c...
AbstractDNA sequence polymorphisms in transthyretin (TrR) genes were investigated by single-strand c...
Amyloidosis is a disorder of protein metabolism characterized by extracellular accumulation of abnor...
AbstractA novel variant transthyretin which contains a leucine-for-valine substitution at position 3...
Transthyretin-associated familial amyloid polyneuropathy (TTR-FAP) is an unusual but life-threatenin...
AbstractOver 70 transthyretin (TTR) mutations have been associated with hereditary amyloidoses, whic...
Familial amyloid polyneuropathy (FAP) is a rare condition caused by mutations of the transthyretin (...
A Japanese family with atypical type I familial amyloidotic polyneuropathy (FAP) in Iiyama, Japan wa...
Mutations of the human transthyretin (TTR) gene have attracted medical interest as a cause of amyloi...
A Dutch family with familial amyloidotic polyneuropathy associated with the transthyretin mutation V...
Transthyretin-related hereditary (TTR) amyloidoses represent a clinically heterogeneous group of dis...
Familial amyloidotic polyneuropathy is a rare autosomal dominant disease, with clinical symptoms beg...
Abstract Transthyretin (TTR)-related familial amyloid polyneuropathy (TTR-FAP) is a life-threatening...
As part of an epidemiological study that aims to characterize chemically the mutation(s) in transthy...
We report on the genetic and molecular characterisation of an Italian family with a late-onset, auto...
Two unrelated Italian families affected by hereditary amyloidosis are described. Molecular genetic c...
AbstractDNA sequence polymorphisms in transthyretin (TrR) genes were investigated by single-strand c...
Amyloidosis is a disorder of protein metabolism characterized by extracellular accumulation of abnor...
AbstractA novel variant transthyretin which contains a leucine-for-valine substitution at position 3...
Transthyretin-associated familial amyloid polyneuropathy (TTR-FAP) is an unusual but life-threatenin...
AbstractOver 70 transthyretin (TTR) mutations have been associated with hereditary amyloidoses, whic...
Familial amyloid polyneuropathy (FAP) is a rare condition caused by mutations of the transthyretin (...
A Japanese family with atypical type I familial amyloidotic polyneuropathy (FAP) in Iiyama, Japan wa...
Mutations of the human transthyretin (TTR) gene have attracted medical interest as a cause of amyloi...
A Dutch family with familial amyloidotic polyneuropathy associated with the transthyretin mutation V...
Transthyretin-related hereditary (TTR) amyloidoses represent a clinically heterogeneous group of dis...
Familial amyloidotic polyneuropathy is a rare autosomal dominant disease, with clinical symptoms beg...
Abstract Transthyretin (TTR)-related familial amyloid polyneuropathy (TTR-FAP) is a life-threatening...